Terms: = Lymphoma AND ARID1B, 6A3-5, 57492, ENSG00000049618, p250R, KIAA1235, ELD/OSA1, DAN15, BRIGHT, BAF250b AND Treatment
66 results:
1. A Bizarre Progression Of Chronic Lymphocytic Leukaemia Into Diffuse Large B-Cell lymphoma.
Shakeel D; Qadir H; Baig MM; Ojla SM
J Ayub Med Coll Abbottabad; 2023; 35(3):512-514. PubMed ID: 38404107
[TBL] [Abstract] [Full Text] [Related]
2. The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders.
Al-Zubaidi HK; Hughes SF
Br J Biomed Sci; 2023; 80():11573. PubMed ID: 37822353
[No Abstract] [Full Text] [Related]
3. Divergent paths: management of early relapsed follicular lymphoma.
Takiar R; Karimi Y; Phillips TJ
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):666-675. PubMed ID: 36485106
[TBL] [Abstract] [Full Text] [Related]
4. A bright Horizon: Immunotherapy for Pediatric T-Cell Malignancies.
Newman H; Teachey DT
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955734
[TBL] [Abstract] [Full Text] [Related]
5. The prognostic role of NKG2A expression for patients with chronic myeloid leukemia after treatment discontinuation.
Xu Z; Yin J; Sun Q; Hu J; Hong M; Qian S; Liu W
Leuk Lymphoma; 2022 Nov; 63(11):2616-2626. PubMed ID: 35758278
[TBL] [Abstract] [Full Text] [Related]
6. Single-cell RNA sequencing to explore composition of peripheral blood NK cells in patients with chronic myeloid leukemia in treatment-free remission.
Yu G; Lu W; Chen X; Li Y; Long J; Zheng Z; Yin C; Xu D
Leuk Lymphoma; 2022 Nov; 63(11):2604-2615. PubMed ID: 35695125
[TBL] [Abstract] [Full Text] [Related]
7. Bispecific Antibodies for Non-Hodgkin lymphoma treatment.
Bock AM; Nowakowski GS; Wang Y
Curr Treat Options Oncol; 2022 Feb; 23(2):155-170. PubMed ID: 35182296
[TBL] [Abstract] [Full Text] [Related]
8. Mechanisms Involved in the Promoting Activity of Fibroblasts in HTLV-1-Mediated lymphomagenesis: Insights into the Plasticity of lymphomatous Cells.
Rigotto G; Montini B; Mattiolo A; Lazzari N; Piano MA; Remondini D; Marmiroli S; Bertacchini J; Chieco-Bianchi L; Calabrò ML
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638901
[TBL] [Abstract] [Full Text] [Related]
9. Immune normalization strategy against suboptimal health status: safe and efficacious therapy using mixed-natural killer cells.
Li Y; Harunori O; Fu S; Xing F; Wu H; Wang J; Chen A; Ren X; Peng D; Ling X; Shi M; Wu H
Aging (Albany NY); 2021 Aug; 13(16):20131-20148. PubMed ID: 34461606
[TBL] [Abstract] [Full Text] [Related]
10. [Clinicopathological features of intravascular peripheral T-cell lymphoma].
Guan X; Yang YC; Qi Y; Gong WC; Xu XY; Wang YL; Guo YH; Luo Y; Sun L; Fu K; Meng B
Zhonghua Xue Ye Xue Za Zhi; 2021 Jul; 42(7):583-590. PubMed ID: 34455746
[No Abstract] [Full Text] [Related]
11. Forsaken Pharmaceutical: Glasdegib in Acute Myeloid Leukemia and Myeloid Diseases.
Feld J; Silverman LR; Navada SC
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e415-e422. PubMed ID: 33547022
[TBL] [Abstract] [Full Text] [Related]
12. Management of Waldenström macroglobulinemia in 2020.
Castillo JJ; Treon SP
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):372-379. PubMed ID: 33275726
[TBL] [Abstract] [Full Text] [Related]
13. Dieulafoy disease with gastric MALT lymphoma: A case report.
Zeng Q; Dai JF; Cao H; Zhang S
Medicine (Baltimore); 2020 Oct; 99(41):e22651. PubMed ID: 33031327
[TBL] [Abstract] [Full Text] [Related]
14. CD20-Negative Nodular Lymphocyte-Predominant Hodgkin lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center.
Menke JR; Spinner MA; Natkunam Y; Warnke RA; Advani RH; Gratzinger DA
Arch Pathol Lab Med; 2021 Jun; 145(6):753-758. PubMed ID: 32991677
[TBL] [Abstract] [Full Text] [Related]
15. Feasibility and Acceptability of Light Therapy to Reduce Fatigue in Adolescents and Young Adults Receiving Cancer-Directed Therapy.
Crabtree VM; LaRosa KN; MacArthur E; Russell K; Wang F; Zhang H; Pan H; Brigden J; Schwartz LE; Wilson M; Pappo A
Behav Sleep Med; 2021; 19(4):492-504. PubMed ID: 32746639
[TBL] [Abstract] [Full Text] [Related]
16. A rare and unusual presentation of Epstein-Barr virus-associated diffuse large B-cell lymphoma involving colon as the primary site.
Modi V; Bajaj N; Lakkasani S; Shaaban HS; Guron G
J Cancer Res Ther; 2020; 16(1):167-169. PubMed ID: 32362630
[TBL] [Abstract] [Full Text] [Related]
17. Imaging findings in hypophysitis: a review.
Caranci F; Leone G; Ponsiglione A; Muto M; Tortora F; Muto M; Cirillo S; Brunese L; Cerase A
Radiol Med; 2020 Mar; 125(3):319-328. PubMed ID: 31863360
[TBL] [Abstract] [Full Text] [Related]
18. Triangle collaboration assessment of autophagy, ER stress and hypoxia in leukemogenesis: a bright perspective on the molecular recognition of B-ALL.
Feizi F; Allahbakhshian Farsani M; Mirzaeian A; Takhviji V; Hajifathali A; Hossein Mohammadi M
Arch Physiol Biochem; 2021 Jun; 127(3):285-289. PubMed ID: 31328564
[TBL] [Abstract] [Full Text] [Related]
19. A review of chimeric antigen receptor T-cells in lymphoma.
Anderson JK; Mehta A
Expert Rev Hematol; 2019 Jul; 12(7):551-561. PubMed ID: 31177852
[No Abstract] [Full Text] [Related]
20. Mantle Cell lymphoma With Mantle Zone Growth Pattern.
Yuan J; Li S; Liu X; Su RJ; Chen M; Wu X; Zheng G; Smith LM; Wang L; Li Y; Liu C; Zhou J; Shen Q; Zhang L; Wang E; Xu ML; Pan Z
Am J Clin Pathol; 2019 Jul; 152(2):132-145. PubMed ID: 31140550
[TBL] [Abstract] [Full Text] [Related]
[Next]
